Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Coordination and Support Action · Finished

Rapidemic Rapidemic – A lysis buffer for a novel molecular point-of-care diagnostic device for sexually transmitted infections

Coordinator
Rapidemic B.v., Netherlands
Runs
1 June 2023 to 31 December 2023
Status
Finished
EU funding
€75k
Total cost
—
Partners
1 organisations in 1 countries
Type
Coordination and Support Action
Grant agreement
101114401

What the project is doing

In the project's own words, from its summary on CORDIS.

Sexually transmitted infections (STI) are some of the most prevalent endemic infections in Europe. Current diagnostic techniques for STI’s have important shortcomings, as they rely on central diagnostic laboratories with extensive high-throughput facilities with expensive equipment and trained personnel. Due to this, the turnover of patient samples can take up to a week. In the meantime, patients are experiencing shame and pain.

This delay in diagnosis can also have more important consequences, such as continued spread of the infections, of the development of pelvic inflammatory disease, which can lead to infertility. This is why Rapidemic develops an innovative molecular point-of-care diagnostic device for fast and accurate diagnosis of chlamydia and gonorroea. With this test, patient samples no longer have to travel to a lab, but patients can immediately get tested at a sexual health clinic.

This single-visit testing provides an opportunity for immediate treatment administration and to drastically reduce the patients discomfort, therby decreasing the barrier to test. To detect a pathogen’s DNA in the Rapidemic test, the bacteria first have to release the DNA. In this project, Rapidemic will be working on the research and development of a novel lysis buffer for gram negative bacteria, suitable for integration in a molecular point-of-care diagnostic device.

Topics

Who is involved

OrganisationCityCountryRole
Rapidemic B.v.LeidenNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI